Elan Corporation selects Amadeus' eQCM(R) software for the management of their compliance worldwide

    QUEBEC CITY, April 19 /CNW Telbec/ - Amadeus International Inc.
(TSX-V: Aii), a pioneer and leader in advanced compliance process control
solutions, announced today that Elan Corporation plc, a neuroscience-based
biotechnology company, customer of Amadeus since 2005, has entered into
extended contractual arrangements to further deploy the eQCM(R) software suite
throughout their locations worldwide.
    Constantly faced with the challenge of complying with cGXP (i.e. current
good manufacturing, laboratory practices and clinical practices) and
guidelines issued by the FDA, the US Department of Health and Human Services,
the Office of Inspector General, and other regulatory agencies, Elan decided
to optimize their corporate quality and compliance processes through the
implementation of an end-to-end compliance process control solution, the
eQCM (R) software suite. Elan was looking for a solution that was scalable and
could adapt to the requirements of each of their operational sites with
minimal customization. With eQCM(R), Elan now enjoys great scalability and
adaptability to manage and control their specific and unique processes, in
line with their regulatory requirements. With the deployment of a single eQCM
platform across all sites, Elan will thus ensure ongoing and consistent
quality and compliance at a substantially optimized total cost of ownership.
    Commenting on this new agreement, Deborah Collins, Vice President of
Corporate Compliance at Elan, said: "We are very pleased to execute this
agreement, which follows on from the successful implementation of eQCM(R) for
the management of our corporate compliance audit program. Through the
deployment of a single compliance platform, we anticipate improved levels of
consistency and control over our compliance processes. Our experience with
Amadeus to date has been positive and productive, and we look forward to an
ongoing partnership."
    "Our relationship with Elan over the years has been outstanding", stated
Pierre-François Isabel, Vice President of Sales and Marketing at Amadeus. We
partnered with them in the successful deployment of eQCM(R) for the corporate
audit program management last year, and will be deploying the compliance
process management for the manufacturing sites in the USA and Ireland next
June. "When Elan's management decided to deploy eQCM(R) in all of their sites
as the corporate quality and compliance platform, we put forward unique
contractual arrangements to allow our software to be used corporate-wide and
for each site to get the same benefits and more as best practices will emerge
internally. In the coming years, we will continue working together in the
deployment of each of their sites through our Professional Services Group", he

    About Elan Corporation

    Elan Corporation, plc (NYSE:   ELN) is a neuroscience-based biotechnology
company committed to making a difference in the lives of patients and their
families by dedicating itself to bringing innovations in science to fill
significant unmet medical needs that continue to exist around the world. Elan
shares trade on the New York, London and Dublin Stock Exchanges. For
additional information about the company, please visit http://www.elan.com.

    About Amadeus International

    Amadeus International is a pioneer and leader in compliance process
control solutions. Its flagship product, eQCM(R), is a flexible, Web-based
integrated suite of applications that allow organizations to manage and
control compliance and quality by automating processes such as document
management, CAPA, non conformances, customer satisfaction, audits, and other
related quality and business processes. The application suite is coupled with
powerful business intelligence capabilities, enterprise content management,
and related technologies that help organizations achieve sustained compliance.
Amadeus International's global headquarters are located in Quebec City,
Canada. Amadeus' solutions are distributed across four continents.

    - The TSX Venture Exchange does not accept responsibility for the
      adequacy or accuracy of this release.

    - Any statement that appears prospective shall not be interpreted as

For further information:

For further information: Manon Rouillier, Marketing and Communications
Director, (418) 525-0606, ext. 2231, manon.rouillier@amadeussolutions.com

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890